ATTOPLEX Co., Ltd.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
ATTOPLEX Co., Ltd. - overview
Established
2019
Location
Hanam, -, South Korea
Primary Industry
Healthcare IT
About
Based in Gyeonggi-do, South Korea, and founded in 2019, ATTOPLEX Co. , Ltd. operates as a biotech company providing home test systems and diagnosis platforms using molecular immunodiagnosis technology. In April 2021, ATTOPLEX Co.
, Ltd raised KRW 2 billion in venture funding from NAU IB Capital and DT&Investment. ATTOPLEX Co. , Ltd. provides molecular diagnostic kits for respiratory infections, gastrointestinal tract infections, human papillomavirus infections, sexually transmitted infections, and bacterial infections.
The company provides home test kits and devices such as device iAmpDX, iAmpDX SARS-CoV-2 LAMP Kit V2, and Kit iAmpDX. In addition, the firm provides products for DNA Ladder (DL), qPCR Master Mix (QM), Molecular Reagents, and Nucleic acid purification Kits.
Current Investors
NAU IB Capital, DT&Investment
Primary Industry
Healthcare IT
Sub Industries
Molecular Science, Genetics & Gene Therapy, Healthcare IT, Medical Devices & Equipment
Website
www.attoplex.co.kr
Verticals
HealthTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
ATTOPLEX Co., Ltd. - financials
| Fiscal Year Ended | Dec 31, 2019 | Dec 31, 2020 | Dec 31, 2021 | Dec 31, 2022 |
|---|---|---|---|---|
| Revenue (USD) | 41,351,000 | - | - | - |
| % Revenue Growth (YoY) | - | - | - | - |
| EBITDA (USD) | - | - | - | - |
| Operating Income (USD) | 1,349,000 | - | - | - |
| Operating Margin | 3.3% | - | - | - |
| % EBITDA Margin | - | - | - | - |
| NET Income (USD) | 1,230,000 | - | - | - |
| % Net Margin | 3.0% | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.